Caxton Associates LP Fulgent Genetics, Inc. Transaction History
Caxton Associates LP
- $2.65 Billion
- Q3 2024
A detailed history of Caxton Associates LP transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 11,432 shares of FLGT stock, worth $216,636. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,432
Previous 25,095
54.45%
Holding current value
$216,636
Previous $492,000
49.59%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding FLGT
# of Institutions
200Shares Held
16MCall Options Held
2.04MPut Options Held
14K-
Black Rock Inc. New York, NY3.92MShares$74.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$27.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$24.1 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$21 Million0.01% of portfolio
-
State Street Corp Boston, MA794KShares$15 Million0.0% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $574M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...